Reports
The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.
RESOURCE LINE
VACCINE
June/July 2008
Clarifying the use of the herpes zoster vaccine Gnann JW Jr. Vaccination to prevent herpes zoster in older adults. J Pain 2008;9(1 suppl 1):S31-S36. The herpes zoster (HZ) vaccine has been approved by the US Food and Drug Administration for...
13th International Congress on Infectious Diseases
Key Vaccinations for Disease Prevention in Adults
Kuala Lumpur, Malaysia / June 19-22, 2008
Immunization to prevent vaccine-preventable illnesses in adults is increasingly vital because the population is aging and is thus more vulnerable to infection. The increasing prevalence of comorbidities in the elderly, including diabetes...
Primary Care Today 2008
Adult Vaccination and Primary Prevention of Post-herpetic Neuralgia
Toronto, Ontario / May 8-10, 2008
Toronto - An estimated 130,000 episodes of shingles occur in Canada every year, resulting in approximately 20,000 annual cases of post-herpetic neuralgia (PHN). Pharmacological strategies to treat acute herpes zoster (HZ) have modest...
RESOURCE LINE
VACCINE
March/April 2008
Cost-effectiveness of a catch-up meningococcal vaccine program Ortega-Sánchez et al. Economics of an adolescent meningococcal conjugate vaccination catch-up campaign in the United States. Clin Infect Dis 2008;46(1):1-13. Catch-up...
RESOURCE LINE
VACCINE
January/February 2008
Updated NACI recommendations:infants and families likely to benefit from the pentavalent rotavirus vaccine Canada Communicable Disease Report (CDDR). Online publication 22 January 2008;34(ACS-1):1-33. The National Advisory Committee on...
Based on the Canada Communicable Disease Report (CCDR) Online publication 22 January 2008;34(ACS-1):1-33.
National Advisory Committee on Immunization Statement on the Use of the Pentavalent Rotavirus Vaccine: New Recommendations for Infants
According to a recent National Advisory Committee on Immunization (NACI) statement published in the Canada Communicable Disease Report, infants and their families are likely to benefit from immunization with a vaccine that would prevent the...
EUROGIN 2007 7th International Multidisciplinary Congress
Clinical Implications of the New Quadrivalent Human Papillomavirus Vaccine
Monte Carlo, Monaco / October 4-6, 2007
As stated by Dr. Monika Hampl, University Hospital, Düsseldorf, Germany, “Cervical cancer is the second most common cause of cancer death among young women in Europe, and every year about 33,000 new cases are diagnosed.”...
47th Interscience Conference on Antimicrobial Agents and Chemotherapy
Results from Follow-up Studies of the Quadrivalent Human Papillomavirus Vaccine: Continued Protection
Chicago, Illinois / September 17-20, 2007
The lifetime risk of sexually active men and women being infected with human papillomavirus (HPV) is at least 50% and in some settings, that risk is as high as 70%. Screening has dramatically reduced the incidence of cervical cancer, but it...
Based on articles from: CMAJ August 2007;177(5):Online 1-4 Maclean’s Magazine August 27, 2007, pp. 38-42
Addressing the Real Burden of Disease: Supporting Current and Future Vaccination Against Human Papillomavirus
August 2007
Editorial Overview: Alex Ferenczy, MD Professor of Pathology and Obstetrics and Gynecology McGill University and the Sir Mortimer B. Davis-Jewish General Hospital Montreal, Quebec and Eduardo L. Franco, PhD Director, Division of Cancer...